You’re Getting The COVID19 Vaccine – Whether You Want It Or Not
At this point, everyone knows: the health perils of the COVID19 vaccines are huge. According to our own government’s data reported in the CDC’s “V-Safe” vaccine safety reporting system:
Out of the approximate 10 million v-safe users, 782,913 individuals, or over 7.7% of v-safe users, had a health event requiring medical attention, emergency room intervention, and/or hospitalization. Another 25% of v-safe users had an event that required them to miss school or work and/or prevented normal activities.
In fact, this data was so bad, that the CDC shut down the V-safe website on June 30, 2023, with no explanation. Dr. Peter McCullough, COVID19 expert and Chief Scientific Officer at The Wellness Company, expresses his dismay on his Substack:
“…my interpretation is that the CDC has now openly turned a blind eye to vaccine safety. The public should be outraged in this overt US government capitulation indicating it simply does not care what happens to people as they take more novel shots.”
A Shocking Next Chapter in COVID-19 Vaccine Development
Despite the overwhelming safety issues, The National Institute of Health (NIH) continues to fund programs seeking to develop novel ways to deliver mRNA vaccines. Science Translational Medicine recently published an NIH study celebrating the accomplishment of effectively delivering the SARS-CoV-2 vaccine in an inhalable vapor form. From the authors:
“An inhalable platform for messenger RNA (mRNA) therapeutics would enable minimally invasive and lung-targeted delivery for a host of pulmonary diseases… Here, we report an inhalable polymer-based vehicle for delivery of therapeutic mRNAs to the lung. We optimized biodegradable poly(amine-co-ester) (PACE) polyplexes for mRNA delivery… We applied this technology to develop a mucosal vaccine for severe acute respiratory syndrome coronavirus 2 and found that intranasal vaccination with spike protein–encoding mRNA polyplexes induced potent cellular and humoral adaptive immunity and protected susceptible mice from lethal viral challenge…”
The Government and Big Pharma are Showing Their Hand.
“The ability to efficiently deliver mRNA to the lung would have applications for vaccine development, gene therapy, and more,” casually remarks the editor of Science.
Chief of Epidemiology at The Wellness Company and vaccine critic Dr. Harvey Risch recently warned in an interview with The Epoch Times:
“We know that the COVID vaccines have done various degrees of damage to the immune system in a fraction of people who’ve taken them. And that damage could be anywhere from getting COVID more often, getting other infectious diseases, and perhaps it may also be cancer in the longer term.”
Drs. Peter McCullough and Harvey Risch both sit on the Chief Medical Board of The Wellness Company, seeking to bring true therapeutic solutions to the market. Their team designed “Spike Support Formula,” which contains the proteolytic enzyme nattokinase plus other extracts that may keep you healthy in as we contend with mRNA-carrying spike protein circulating in our environment.
In The Wellness Company’s Spike Support Formula you will find:
- Nattokinase (enzyme that may boost immunity towards spike protein)
- Selenium (may aid in helping the body repair itself and recover)
- Dandelion root (may prevent spike protein from binding to cells)
- Black sativa extract (may facilitate cellular repair)
- Green tea extract (may provide antioxidant effects cellular level through scavenging for free radicals)
- Irish sea moss (could help keep tissue and muscle strong)
Here is The Wellness Company’s Dr. Peter McCullough discussing how nattokinase works in attacking the dangerous spike protein:
Support these freedom-fighting doctors and your health today!
Click here to order the Spike Support Formula!
Subscribe to DailyClout so you never miss an update!
The fabric of this company has been woven together by its medical team, whose courage and bravery in their fight for medical freedom and truth as well as their devotion to the public, will help to ensure improved health outcomes, convenient access to physicians, and lower costs of healthcare for their patients.